Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Agnosia × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Skin Neoplasms 1 Sedation 1 Respiratory Aspiration 1 Respiration Disorders 1 Rectal Neoplasms 1 Rare Diseases 1 Pain 1 Neoplasms 1 Glioma 1 Emergence Delirium 1 Diverticulosis, Colonic 1 Cough 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Anxiety Disorders 1 Agnosia 1

Interventions

Anesthesia, General 5 Dexmedetomidine 4 Bupivacaine 4 Anesthesia, Local 4 Acupuncture Therapy 4 parecoxib 2 Transcutaneous Electric Nerve Stimulation 2 Saline Solution 2 Ropivacaine 2 Pregabalin 2 Morphine 2 Fentanyl 2 Ethanol 2 Dental Occlusion 2 Control Groups 2 Anesthetics, Local 2 Anesthesia, Conduction 2 Analgesics, Opioid 2 loxoprofen 1 engage 8200 1 Yoga 1 Uterine Myomectomy 1 Transcranial Direct Current Stimulation 1 Tramadol 1 Touch 1 Telemedicine 1 Surgical Instruments 1 Standard of Care 1 Sodium Chloride 1 S-Adenosylmethionine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04597268 2023-01-10

Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures

National Cancer Institute, Egypt

Phase NA Completed

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡